(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -11.88%156.07M | -24.55%74.41M | -16.09%177.11M | -7.60%98.62M | 14.44%211.08M | 10.49%106.73M | 30.97%184.44M | --96.59M | 7.78%140.83M | --130.66M |
Operating income | -11.88%156.07M | -24.55%74.41M | -16.09%177.11M | -7.60%98.62M | 14.44%211.08M | 10.49%106.73M | 30.97%184.44M | 96.59M | 7.78%140.83M | 130.66M |
Cost of sales | 26.49%-70.67M | 47.14%-31.18M | 28.99%-96.14M | 16.13%-59M | -10.19%-135.38M | -3.35%-70.34M | -30.13%-122.86M | ---68.06M | 0.96%-94.41M | ---95.33M |
Operating expenses | 26.49%-70.67M | 47.14%-31.18M | 28.99%-96.14M | 16.13%-59M | -10.19%-135.38M | -3.35%-70.34M | -30.13%-122.86M | -68.06M | 0.96%-94.41M | -95.33M |
Gross profit | 5.47%85.41M | 9.09%43.23M | 6.97%80.98M | 8.90%39.63M | 22.94%75.7M | 27.54%36.39M | 32.66%61.58M | 28.53M | 31.35%46.42M | 35.34M |
Selling expenses | -13.16%-26.56M | -8.54%-13.3M | 5.89%-23.47M | -5.41%-12.25M | -47.10%-24.94M | -24.49%-11.62M | -42.21%-16.96M | ---9.34M | -0.28%-11.92M | ---11.89M |
Administrative expenses | 47.87%-14.33M | 0.12%-6.54M | -54.05%-27.5M | 29.14%-6.55M | -360.26%-17.85M | -501.95%-9.25M | -9.92%-3.88M | ---1.54M | 12.09%-3.53M | ---4.01M |
Research and development expenses | -181.92%-1.53M | -296.76%-734K | -36.87%-542K | 10.19%-185K | 66.58%-396K | -68.85%-206K | 12.80%-1.19M | ---122K | 43.45%-1.36M | ---2.4M |
Impairment and provision | -2,039.00%-4.28M | -1,008.06%-1.37M | -373.97%-200K | 10.79%-124K | 159.84%73K | -172.55%-139K | -17.31%-122K | ---51K | -215.15%-104K | ---33K |
-Other impairment is provision | -2,039.00%-4.28M | -1,008.06%-1.37M | -373.97%-200K | 10.79%-124K | 159.84%73K | -172.55%-139K | -17.31%-122K | ---51K | -215.15%-104K | ---33K |
Special items of operating profit | -53.18%809K | 17.99%1.94M | 61.50%1.73M | 39.81%1.64M | 198.05%1.07M | 71.74%1.17M | 145.89%359K | --683K | 135.48%146K | --62K |
Operating profit | 27.48%39.51M | 4.79%23.21M | -7.91%30.99M | 35.52%22.15M | -15.43%33.65M | -10.03%16.35M | 34.22%39.79M | 18.17M | 73.77%29.65M | 17.06M |
Financing cost | 16.49%-861K | 38.75%-403K | -72.70%-1.03M | -110.22%-658K | 24.33%-597K | -5.74%-313K | -1,447.06%-789K | ---296K | -628.57%-51K | ---7K |
Earning before tax | 29.00%38.65M | 6.12%22.81M | -9.36%29.96M | 34.06%21.49M | -15.24%33.06M | -10.29%16.03M | 31.79%39M | 17.87M | 73.55%29.6M | 17.05M |
Tax | 8.12%-10.73M | -9.70%-6.68M | -16.89%-11.68M | -25.20%-6.09M | -0.29%-9.99M | -7.89%-4.87M | -36.98%-9.96M | ---4.51M | -61.43%-7.27M | ---4.5M |
After-tax profit from continuing operations | 52.70%27.92M | 4.70%16.13M | -20.73%18.29M | 37.92%15.4M | -20.57%23.07M | -16.43%11.17M | 30.10%29.04M | 13.36M | 77.89%22.32M | 12.55M |
Earning after tax | 52.70%27.92M | 4.70%16.13M | -20.73%18.29M | 37.92%15.4M | -20.57%23.07M | -16.43%11.17M | 30.10%29.04M | 13.36M | 77.89%22.32M | 12.55M |
Minority profit | 3.80%355K | 106.98%178K | 157.14%342K | 19.44%86K | --133K | --72K | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | 53.63%27.57M | 4.13%15.95M | -21.76%17.94M | 38.04%15.32M | -21.03%22.94M | -16.97%11.1M | 30.10%29.04M | 13.36M | 77.89%22.32M | 12.55M |
Basic earnings per share | 50.00%0.03 | 0.00%0.02 | -33.33%0.02 | 0.02 | 0.03 | |||||
Diluted earnings per share | 0.00%0.02 | 0.02 | 0.03 | |||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data